• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

An observational study on bacteriological and morphological index on slit skin smear of biopsy proven cases of leprosy from WHO recommended sites versus hidden sites

    Dr. Ayushi Sthapak Karsoliya, Dr. Tarang Goyal, Dr. Richa Tayal, Dr. Sakshi Kohli

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 3919-3925

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: The bacteriological and morphological status of leprosy patients is assessed by Slit Skin Smear (SSS) method. Bacteriological index (BI) is the semi quantitative index for measuring bacterial load and morphological index (MI) is for assessment of chemotherapeutic efficacy and bacterial resistance.
Aims: To evaluate Bacteriological index and Morphological index on Slit Skin Smear in world health organization (WHO) recommended sites vs other reported hidden sites in untreated and relapsed cases of leprosy.
Methods: 75 patients with biopsy proven leprosy, not on treatment or relapsed cases, irrespective of age, sex and duration of disease were included. Smears were taken from 3 WHO recommended sites (two lesional sites and one ear lobe) and 5 other reported hidden sites (left ear lobe, right hand middle phalynx, right elbow, left eyebrow and left foot great toe).  Slides were stained using Ziehl-Nelson method. BI and MI were evaluated using Ridley's algorithmic scale.
Results: Ear lobes gave uniformly higher values of BI and MI as compared to elbows, fingers and toes. Slit Skin Smear was found to be positive from only peripheral sites in 8 patients. While in 5 cases were positive only from the lesional sites whereas 2 patients out of 75 were positive only from earlobes. Morphological indices were better observed in untreated cases. Ear lobules gave higher morphological index. Maximum number showed bacilli in the lesions and ear lobules followed by toes, elbow, eyebrows and fingers. In 25 out of 75 patients, no bacilli could be seen at any sites.
Conclusion: In a few cases bacilli were seen only in peripheral hidden sites while the WHO recommended sites were negative. Thus, it is important to take SSS from hidden sites.
Keywords:
  • PDF (232 K)
  • XML
(2022). An observational study on bacteriological and morphological index on slit skin smear of biopsy proven cases of leprosy from WHO recommended sites versus hidden sites. European Journal of Molecular & Clinical Medicine, 9(4), 3919-3925.
Dr. Ayushi Sthapak Karsoliya, Dr. Tarang Goyal, Dr. Richa Tayal, Dr. Sakshi Kohli. "An observational study on bacteriological and morphological index on slit skin smear of biopsy proven cases of leprosy from WHO recommended sites versus hidden sites". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 3919-3925.
(2022). 'An observational study on bacteriological and morphological index on slit skin smear of biopsy proven cases of leprosy from WHO recommended sites versus hidden sites', European Journal of Molecular & Clinical Medicine, 9(4), pp. 3919-3925.
An observational study on bacteriological and morphological index on slit skin smear of biopsy proven cases of leprosy from WHO recommended sites versus hidden sites. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 3919-3925.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 84
  • PDF Download: 211
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus